December 2019 FDA Recall Drug by Akorn, Inc.
D-1388-2020 - Chemical contamination; out of specification results obtained for equipment cleaning residue rinse sample

This Class III drug recall was voluntarily initiated by Akorn, Inc. on December 26, 2019 for the product Drug. The FDA reported the reason for recall as chemical contamination; out of specification results obtained for equipment cleaning residue rinse sample. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1388-2020

Reason for Recall
Chemical contamination; out of specification results obtained for equipment cleaning residue rinse sample
Initiated
12-26-2019
Reported
07-22-2020
Quantity
33,343 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Nationwide USA and Puerto Rico
Proparacaine Hydrochloride Ophthalmic Solution, USP, 0.5%, 15 mL per dropper bottle, Sterile, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC 17478-263-12

Batch or Lot Expiration Information

Lot# Lot 9E52A, exp 04/2021